Ulcerative Colitis Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Type (Biologics, Corticosteroids, Immunomodulators 5-aminosalicylic acid, Immunosuppressant, Biosimilars, Others); Administration (Oral, Injectable); Application (Proctosigmoiditis, Ulcerative proctitis, Pancolitis Left-sided colitis, Acute severe ulcerative colitis)

Report Code: TIPRE00019336 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Ulcerative colitis is a chronic condition of the large intestine or colon that causes the colon to weaken. Unknown to researchers, however, is the cause of ulcerative colitis, which is an abnormal immune response to a microbial stimulus. Inflammation of the colon, including signs of stool blood, diarrhoea, and stomach pain, characterises UC.

MARKET DYNAMICS

Ulcerative colitis drugs have increased demand for relief and control of the signs and symptoms of this condition by focusing on diagnesis and recovery. There is currently no permanent treatment for ulcerative colitis and it is not clear precisely why it occurs.

MARKET SCOPE

The "Ulcerative Colitis Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Ulcerative Colitis Drugs Market with detailed market segmentation by drug type, route of administration , application. The Ulcerative Colitis Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Ulcerative Colitis Drugs Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Ulcerative Colitis Drugs Market is segmented on the basis of drug type, route of administration, application. Based on drug type, the market is segmented as Biologics, Corticosteroids, Immunomodulators 5-aminosalicylic acid, Immunosuppressant, Biosimilars, Others. Based on route of administration, the market is segmented as Oral, Injectable. Based on application, the market is segmented as Proctosigmoiditis, Ulcerative proctitis, Pancolitis Left-sided colitis, Acute severe ulcerative colitis.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Ulcerative Colitis Drugs Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Ulcerative Colitis Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Ulcerative Colitis Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Ulcerative Colitis Drugs Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Ulcerative Colitis Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Ulcerative Colitis Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Ulcerative Colitis Drugs Market in the global market. Below mentioned is the list of few companies engaged in the Ulcerative Colitis Drugs Market.

The report also includes the profiles of key players in Ulcerative Colitis Drugs Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Bausch Health Companies Inc. (Salix Pharmaceutical)
  •   AbbVie Inc.
  •   Johnson and Johnson
  •   Boehringer Ingelheim GmbH
  •   Novartis AG
  •   Merck & Co.
  •   Teva Pharmaceuticals Ltd.
  •   Takeda Pharmaceuticals
  •   Shire
  •   Pfizer Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Ulcerative Colitis Drugs Market - By Drug Type
1.3.2 Ulcerative Colitis Drugs Market - By Route of Administration
1.3.3 Ulcerative Colitis Drugs Market - By Application
1.3.4 Ulcerative Colitis Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ULCERATIVE COLITIS DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ULCERATIVE COLITIS DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ULCERATIVE COLITIS DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ULCERATIVE COLITIS DRUGS - GLOBAL MARKET OVERVIEW
6.2. ULCERATIVE COLITIS DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ULCERATIVE COLITIS DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. BIOLOGICS
7.3.1. Overview
7.3.2. Biologics Market Forecast and Analysis
7.4. CORTICOSTEROIDS
7.4.1. Overview
7.4.2. Corticosteroids Market Forecast and Analysis
7.5. IMMUNOMODULATORS 5-AMINOSALICYLIC ACID
7.5.1. Overview
7.5.2. Immunomodulators 5-aminosalicylic acid Market Forecast and Analysis
7.6. IMMUNOSUPPRESSANT
7.6.1. Overview
7.6.2. Immunosuppressant Market Forecast and Analysis
7.7. BIOSIMILARS
7.7.1. Overview
7.7.2. Biosimilars Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. ULCERATIVE COLITIS DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INJECTABLE
8.4.1. Overview
8.4.2. Injectable Market Forecast and Analysis
9. ULCERATIVE COLITIS DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. PROCTOSIGMOIDITIS
9.3.1. Overview
9.3.2. Proctosigmoiditis Market Forecast and Analysis
9.4. ULCERATIVE PROCTITIS
9.4.1. Overview
9.4.2. Ulcerative proctitis Market Forecast and Analysis
9.5. PANCOLITIS LEFT-SIDED COLITIS
9.5.1. Overview
9.5.2. Pancolitis Left-sided colitis Market Forecast and Analysis
9.6. ACUTE SEVERE ULCERATIVE COLITIS
9.6.1. Overview
9.6.2. Acute severe ulcerative colitis Market Forecast and Analysis
10. ULCERATIVE COLITIS DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Ulcerative Colitis Drugs Market Overview
10.1.2 North America Ulcerative Colitis Drugs Market Forecasts and Analysis
10.1.3 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.1.4 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.1.6 North America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Ulcerative Colitis Drugs Market
10.1.6.1.1 United States Ulcerative Colitis Drugs Market by Drug Type
10.1.6.1.2 United States Ulcerative Colitis Drugs Market by Route of Administration
10.1.6.1.3 United States Ulcerative Colitis Drugs Market by Application
10.1.6.2 Canada Ulcerative Colitis Drugs Market
10.1.6.2.1 Canada Ulcerative Colitis Drugs Market by Drug Type
10.1.6.2.2 Canada Ulcerative Colitis Drugs Market by Route of Administration
10.1.6.2.3 Canada Ulcerative Colitis Drugs Market by Application
10.1.6.3 Mexico Ulcerative Colitis Drugs Market
10.1.6.3.1 Mexico Ulcerative Colitis Drugs Market by Drug Type
10.1.6.3.2 Mexico Ulcerative Colitis Drugs Market by Route of Administration
10.1.6.3.3 Mexico Ulcerative Colitis Drugs Market by Application
10.2. EUROPE
10.2.1 Europe Ulcerative Colitis Drugs Market Overview
10.2.2 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis
10.2.3 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.2.6 Europe Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Ulcerative Colitis Drugs Market
10.2.6.1.1 Germany Ulcerative Colitis Drugs Market by Drug Type
10.2.6.1.2 Germany Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.1.3 Germany Ulcerative Colitis Drugs Market by Application
10.2.6.2 France Ulcerative Colitis Drugs Market
10.2.6.2.1 France Ulcerative Colitis Drugs Market by Drug Type
10.2.6.2.2 France Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.2.3 France Ulcerative Colitis Drugs Market by Application
10.2.6.3 Italy Ulcerative Colitis Drugs Market
10.2.6.3.1 Italy Ulcerative Colitis Drugs Market by Drug Type
10.2.6.3.2 Italy Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.3.3 Italy Ulcerative Colitis Drugs Market by Application
10.2.6.4 Spain Ulcerative Colitis Drugs Market
10.2.6.4.1 Spain Ulcerative Colitis Drugs Market by Drug Type
10.2.6.4.2 Spain Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.4.3 Spain Ulcerative Colitis Drugs Market by Application
10.2.6.5 United Kingdom Ulcerative Colitis Drugs Market
10.2.6.5.1 United Kingdom Ulcerative Colitis Drugs Market by Drug Type
10.2.6.5.2 United Kingdom Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Ulcerative Colitis Drugs Market by Application
10.2.6.6 Rest of Europe Ulcerative Colitis Drugs Market
10.2.6.6.1 Rest of Europe Ulcerative Colitis Drugs Market by Drug Type
10.2.6.6.2 Rest of Europe Ulcerative Colitis Drugs Market by Route of Administration
10.2.6.6.3 Rest of Europe Ulcerative Colitis Drugs Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Ulcerative Colitis Drugs Market Overview
10.3.2 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Ulcerative Colitis Drugs Market
10.3.6.1.1 Australia Ulcerative Colitis Drugs Market by Drug Type
10.3.6.1.2 Australia Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.1.3 Australia Ulcerative Colitis Drugs Market by Application
10.3.6.2 China Ulcerative Colitis Drugs Market
10.3.6.2.1 China Ulcerative Colitis Drugs Market by Drug Type
10.3.6.2.2 China Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.2.3 China Ulcerative Colitis Drugs Market by Application
10.3.6.3 India Ulcerative Colitis Drugs Market
10.3.6.3.1 India Ulcerative Colitis Drugs Market by Drug Type
10.3.6.3.2 India Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.3.3 India Ulcerative Colitis Drugs Market by Application
10.3.6.4 Japan Ulcerative Colitis Drugs Market
10.3.6.4.1 Japan Ulcerative Colitis Drugs Market by Drug Type
10.3.6.4.2 Japan Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.4.3 Japan Ulcerative Colitis Drugs Market by Application
10.3.6.5 South Korea Ulcerative Colitis Drugs Market
10.3.6.5.1 South Korea Ulcerative Colitis Drugs Market by Drug Type
10.3.6.5.2 South Korea Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.5.3 South Korea Ulcerative Colitis Drugs Market by Application
10.3.6.6 Rest of Asia-Pacific Ulcerative Colitis Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Ulcerative Colitis Drugs Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific Ulcerative Colitis Drugs Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Ulcerative Colitis Drugs Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Ulcerative Colitis Drugs Market Overview
10.4.2 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Ulcerative Colitis Drugs Market
10.4.6.1.1 South Africa Ulcerative Colitis Drugs Market by Drug Type
10.4.6.1.2 South Africa Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.1.3 South Africa Ulcerative Colitis Drugs Market by Application
10.4.6.2 Saudi Arabia Ulcerative Colitis Drugs Market
10.4.6.2.1 Saudi Arabia Ulcerative Colitis Drugs Market by Drug Type
10.4.6.2.2 Saudi Arabia Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Ulcerative Colitis Drugs Market by Application
10.4.6.3 U.A.E Ulcerative Colitis Drugs Market
10.4.6.3.1 U.A.E Ulcerative Colitis Drugs Market by Drug Type
10.4.6.3.2 U.A.E Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Ulcerative Colitis Drugs Market by Application
10.4.6.4 Rest of Middle East and Africa Ulcerative Colitis Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Ulcerative Colitis Drugs Market by Drug Type
10.4.6.4.2 Rest of Middle East and Africa Ulcerative Colitis Drugs Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Ulcerative Colitis Drugs Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Ulcerative Colitis Drugs Market Overview
10.5.2 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis
10.5.3 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Application
10.5.6 South and Central America Ulcerative Colitis Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Ulcerative Colitis Drugs Market
10.5.6.1.1 Brazil Ulcerative Colitis Drugs Market by Drug Type
10.5.6.1.2 Brazil Ulcerative Colitis Drugs Market by Route of Administration
10.5.6.1.3 Brazil Ulcerative Colitis Drugs Market by Application
10.5.6.2 Argentina Ulcerative Colitis Drugs Market
10.5.6.2.1 Argentina Ulcerative Colitis Drugs Market by Drug Type
10.5.6.2.2 Argentina Ulcerative Colitis Drugs Market by Route of Administration
10.5.6.2.3 Argentina Ulcerative Colitis Drugs Market by Application
10.5.6.3 Rest of South and Central America Ulcerative Colitis Drugs Market
10.5.6.3.1 Rest of South and Central America Ulcerative Colitis Drugs Market by Drug Type
10.5.6.3.2 Rest of South and Central America Ulcerative Colitis Drugs Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Ulcerative Colitis Drugs Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ULCERATIVE COLITIS DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ULCERATIVE COLITIS DRUGS MARKET, KEY COMPANY PROFILES
13.1. BAUSCH HEALTH COMPANIES INC. (SALIX PHARMACEUTICAL)
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBVIE INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. JOHNSON AND JOHNSON
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BOEHRINGER INGELHEIM GMBH
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NOVARTIS AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MERCK AND CO
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. TEVA PHARMACEUTICALS LTD.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. TAKEDA PHARMACEUTICALS
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SHIRE
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PFIZER INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Bausch Health Companies Inc. (Salix Pharmaceutical)
2. AbbVie Inc.
3. Johnson and Johnson
4. Boehringer Ingelheim GmbH
5. Novartis AG
6. Merck & Co.
7. Teva Pharmaceuticals Ltd.
8. Takeda Pharmaceuticals
9. Shire
10. Pfizer Inc.
TIPRE00019336
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking